EuropeSouth AsiaAsia PacificAmericasMiddle EastAfricaBBC HomepageWorld ServiceEducation
News image
News image
News image
News imageNews image
News image
Front Page
News image
World
News image
UK
News image
UK Politics
News image
Business
News image
Sci/Tech
News image
Health
News image
Education
News image
Sport
News image
Entertainment
News image
Talking Point
News image
In Depth
News image
On Air
News image
Archive
News image
News image
News image
Feedback
Low Graphics
Help
News imageNews imageNews image
News imageThursday, March 11, 1999 Published at 00:37 GMT
News image
News image
Health
News image
Early detection test for bladder cancer
News image
The VEGF test could save lives
News image
A test for measuring the level of a chemical growth factor found in the urine of people with bladder cancer could help save thousands of lives.

Scientists at the Imperial Cancer Research Fund say they have found that patients with high levels of vascular endothelial growth factor (VEGF) are at greater risk of developing bladder cancer.

The cancer affects thousands every year and is three times more common in men than in women. It mostly affects the elderly.

If caught early the chances of surviving it are much better.

Blood vessel growth

The scientists have measured VEGF levels in cancer patients' urine for the first time.

The growth factor stimulates the development of blood vessels to feed the tumour and allow it to spread.

Led by Professor Adrian Harris, Director of the Imperial Cancer's Medical Oncology Unit, the team studied 261 people with bladder cancer and compared them with people with no disease or other types of tumours.

The patients with bladder cancer had far higher levels of VEGF in their urine.

The scientists also found a link between the amount of VEGF in the urine and the likelihood of cancer recurring.

This could mean that the test could provide a simple, quick, safe and relatively cheap way of predicting if the cancer will recur.

Uncomfortable treatment

There are many different forms of bladder cancer and they behave in very different ways.

Some are easier to treat than others. Also, some patients respond well to treatment while in others the cancer keeps recurring.

Currently, these patients have to undergo regular check-ups.

This involves either a cystoscope tube being inserted in the urethra, which can be uncomfortable, or patients providing urine samples which are examined under the microscope in the laboratory.

The scientists say the VEGF test is more accurate than the lab tests.

Cancer treatments

Professor Harris says that, if VEGF is as important in the development of bladder cancer as the study suggests, it may be worth studying ways of inhibiting it.

This could lead to the development of new drugs which could help treat the cancer.

"Deprived of the growth-promoting substances the tumours need, and so of their capacity to make new blood vessels, tumours might be effectively starved into submission," he said.

It is not known what causes bladder cancer, but risk factors are thought to include smoking and exposure to some chemicals at work, including rubber.

Symptoms of the disease include blood in the urine and a burning feeling which does not go away after treatment with antibiotics.

Over 54,000 people in the USA develop bladder cancer every year. Around 11,700 die from the disease.

News image


Advanced options | Search tips


News image
News image
News imageBack to top | BBC News Home | BBC Homepage |
News image

News imageNews imageNews image
Health Contents
News image
News imageBackground Briefings
News imageMedical notes
News imageNews image
Relevant Stories
News image
05 Feb 99�|�Health
Best cancer treatment 'a human right'
News image
05 Jan 99�|�Health
Dental risk for cancer children
News image
05 Jan 99�|�Health
Hopes for gentler cancer treatment
News image
11 Mar 99�|�Health
A million celebrate life after the Big C
News image

News image
News image
News image
News imageInternet Links
News image
News imageNews image
CancerBACUP
News image
Bladder cancer
News image
Imperial Cancer Research Fund
News image
News imageNews image
The BBC is not responsible for the content of external internet sites.

News image
News image
News image
News imageIn this section
News image
Disability in depth
News image
Spotlight: Bristol inquiry
News image
Antibiotics: A fading wonder
News image
Mental health: An overview
News image
Alternative medicine: A growth industry
News image
The meningitis files
News image
Long-term care: A special report
News image
Aids up close
News image
From cradle to grave
News image
NHS reforms: A guide
News image
NHS Performance 1999
News image
From Special Report
NHS in crisis: Special report
News image
British Medical Association conference '99
News image
Royal College of Nursing conference '99
News image

News image
News image
News image